Stran & Company, Inc. Quarterly report [Sections 13 or 15(d)]

Income (Loss) Per Share - Schedule of Diluted Net Income Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Schedule of Diluted Net Income (Loss) Per Share [Line Items]
Total anti-dilutive	11,337,695	11,484,694	11,337,695	11,484,694
Warrants [Member]
Schedule of Diluted Net Income (Loss) Per Share [Line Items]
Total anti-dilutive	10,074,195	10,074,195	10,074,195	10,074,195
Stock options [Member]
Schedule of Diluted Net Income (Loss) Per Share [Line Items]
Total anti-dilutive	1,263,500	1,410,499	1,263,500	1,410,499